AE summary table — gt_ae_summary • metalite.ae

AE summary table

Usage

gt_ae_summary(
  outdata,
  source,
  analysis,
  col_rel_width = NULL,
  text_font_size = 9,
  orientation = "portrait",
  title = c("analysis", "observation", "population"),
  footnotes = NULL,
  path_outdata = NULL,
  path_outtable = NULL
)

Arguments

outdata: An outdata object created by prepare_ae_specific().
source: A character value of the data source.
analysis: One of analysis name existing at outdata$meta$analysis
col_rel_width: Column relative width in a vector e.g. c(2,1,1) refers to 2:1:1. Default is NULL for equal column width.
text_font_size: Text font size. To vary text font size by column, use numeric vector with length of vector equal to number of columns displayed e.g. c(9,20,40).
orientation: Orientation in 'portrait' or 'landscape'.
title: Term "analysis", "observation"and "population") for collecting title from metadata or a character vector of table titles.
footnotes: A character vector of table footnotes.
path_outdata: A character string of the outdata path.
path_outtable: A character string of the outtable path.

Value

RTF file and the source dataset for AE summary table.

Examples

library(gt)
meta <- meta_ae_example()
outdata <- prepare_ae_summary(meta,
  population = "apat",
  observation = "wk12",
  parameter = "any;rel;ser"
)
#> any
#> rel
#> ser
outdata |>
  format_ae_summary() |>
  gt_ae_summary(
    analysis = "ae_summary",
    source = "Source:  [CDISCpilot: adam-adsl; adae]"
  )
#> [1] "Summary of Adverse Events"   "Weeks 0 to 12"              
#> [3] "All Participants as Treated"


  Summary of Adverse Events

Weeks 0 to 12

All Participants as Treated
    

      
        Placebo
      
      
        Low Dose
      
      
        High Dose
      
      
        Total
      
    
n
      (%)
      n
      (%)
      n
      (%)
      n
      (%)
    
Participants in population
86


84


84


254

with one or more adverse events
69
(80.2)
77
(91.7)
79
(94.0)
225
(88.6)
with no adverse events
17
(19.8)
7
 (8.3)
5
 (6.0)
29
(11.4)
with drug-related^a adverse events
44
(51.2)
73
(86.9)
70
(83.3)
187
(73.6)
with serious adverse events
0
 (0.0)
1
 (1.2)
2
 (2.4)
3
 (1.2)
^aDetermined by the investigator to be related to the drug.
    
Source:  [CDISCpilot: adam-adsl; adae]

	Placebo		Low Dose		High Dose		Total
Summary of Adverse Events Weeks 0 to 12 All Participants as Treated
	n	(%)	n	(%)	n	(%)	n	(%)
Participants in population	86		84		84		254
with one or more adverse events	69	(80.2)	77	(91.7)	79	(94.0)	225	(88.6)
with no adverse events	17	(19.8)	7	(8.3)	5	(6.0)	29	(11.4)
with drug-related^a adverse events	44	(51.2)	73	(86.9)	70	(83.3)	187	(73.6)
with serious adverse events	0	(0.0)	1	(1.2)	2	(2.4)	3	(1.2)
^aDetermined by the investigator to be related to the drug.
Source: [CDISCpilot: adam-adsl; adae]